As we know that biologicals are an increasing interest for the pharmaceutical companies , especially in the field of oncology, LBS has decided to redesign their Biologicals Simulation. In the past the simulation was focussed on MS, but the new set-up of the course will focus on monoclonal antibodies in the field of oncology. We are working on both an in-life version of this course and an on-line version. It is expected that the first roll-out will be in Q3 2021.
Please visit this website for regular updates.
Interested? Please contact us at firstname.lastname@example.org